China Dihydroartemisinin Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Dihydroartemisinin Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Dihydroartemisinin Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Dihydroartemisinin Overall Market Size
2.1 China Dihydroartemisinin Market Size: 2021 VS 2027
2.2 China Dihydroartemisinin Revenue, Prospects & Forecasts: 2016-2027
2.3 China Dihydroartemisinin Sales: 2016-2027
3 Company Landscape
3.1 Top Dihydroartemisinin Players in China Market
3.2 Top China Dihydroartemisinin Companies Ranked by Revenue
3.3 China Dihydroartemisinin Revenue by Companies
3.4 China Dihydroartemisinin Sales by Companies
3.5 China Dihydroartemisinin Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Dihydroartemisinin Companies in China Market, by Revenue in 2020
3.7 Manufacturers Dihydroartemisinin Product Type
3.8 Tier 1, Tier 2 and Tier 3 Dihydroartemisinin Players in China Market
3.8.1 List of Tier 1 Dihydroartemisinin Companies in China
3.8.2 List of Tier 2 and Tier 3 Dihydroartemisinin Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Dihydroartemisinin Market Size Markets, 2021 & 2027
4.1.2 Pharmaceutical Grade
4.1.3 Industrial Grade
4.2 By Type - China Dihydroartemisinin Revenue & Forecasts
4.2.1 By Type - China Dihydroartemisinin Revenue, 2016-2021
4.2.2 By Type - China Dihydroartemisinin Revenue, 2022-2027
4.2.3 By Type - China Dihydroartemisinin Revenue Market Share, 2016-2027
4.3 By Type - China Dihydroartemisinin Sales & Forecasts
4.3.1 By Type - China Dihydroartemisinin Sales, 2016-2021
4.3.2 By Type - China Dihydroartemisinin Sales, 2022-2027
4.3.3 By Type - China Dihydroartemisinin Sales Market Share, 2016-2027
4.4 By Type - China Dihydroartemisinin Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Dihydroartemisinin Market Size, 2021 & 2027
5.1.2 Malaria Treatment
5.1.3 Scientific Research
5.1.4 Others
5.2 By Application - China Dihydroartemisinin Revenue & Forecasts
5.2.1 By Application - China Dihydroartemisinin Revenue, 2016-2021
5.2.2 By Application - China Dihydroartemisinin Revenue, 2022-2027
5.2.3 By Application - China Dihydroartemisinin Revenue Market Share, 2016-2027
5.3 By Application - China Dihydroartemisinin Sales & Forecasts
5.3.1 By Application - China Dihydroartemisinin Sales, 2016-2021
5.3.2 By Application - China Dihydroartemisinin Sales, 2022-2027
5.3.3 By Application - China Dihydroartemisinin Sales Market Share, 2016-2027
5.4 By Application - China Dihydroartemisinin Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Overview
6.1.3 Sanofi Dihydroartemisinin Sales and Revenue in China Market (2016-2021)
6.1.4 Sanofi Dihydroartemisinin Product Description
6.1.5 Sanofi Recent Developments
6.2 KPC Pharmaceuticals
6.2.1 KPC Pharmaceuticals Corporation Information
6.2.2 KPC Pharmaceuticals Overview
6.2.3 KPC Pharmaceuticals Dihydroartemisinin Sales and Revenue in China Market (2016-2021)
6.2.4 KPC Pharmaceuticals Dihydroartemisinin Product Description
6.2.5 KPC Pharmaceuticals Recent Developments
6.3 Guangxi Xiancaotang Pharmaceutical
6.3.1 Guangxi Xiancaotang Pharmaceutical Corporation Information
6.3.2 Guangxi Xiancaotang Pharmaceutical Overview
6.3.3 Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Sales and Revenue in China Market (2016-2021)
6.3.4 Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Product Description
6.3.5 Guangxi Xiancaotang Pharmaceutical Recent Developments
6.4 Guilin Pharmaceutical
6.4.1 Guilin Pharmaceutical Corporation Information
6.4.2 Guilin Pharmaceutical Overview
6.4.3 Guilin Pharmaceutical Dihydroartemisinin Sales and Revenue in China Market (2016-2021)
6.4.4 Guilin Pharmaceutical Dihydroartemisinin Product Description
6.4.5 Guilin Pharmaceutical Recent Developments
6.5 Kerui Nanhai Pharmaceutical
6.5.1 Kerui Nanhai Pharmaceutical Corporation Information
6.5.2 Kerui Nanhai Pharmaceutical Overview
6.5.3 Kerui Nanhai Pharmaceutical Dihydroartemisinin Sales and Revenue in China Market (2016-2021)
6.5.4 Kerui Nanhai Pharmaceutical Dihydroartemisinin Product Description
6.5.5 Kerui Nanhai Pharmaceutical Recent Developments
6.6 Shanghai Natural Bio-engineering Co
6.6.1 Shanghai Natural Bio-engineering Co Corporation Information
6.6.2 Shanghai Natural Bio-engineering Co Overview
6.6.3 Shanghai Natural Bio-engineering Co Dihydroartemisinin Sales and Revenue in China Market (2016-2021)
6.6.4 Shanghai Natural Bio-engineering Co Dihydroartemisinin Product Description
6.6.5 Shanghai Natural Bio-engineering Co Recent Developments
6.7 Novanat Bioresource
6.7.1 Novanat Bioresource Corporation Information
6.7.2 Novanat Bioresource Overview
6.7.3 Novanat Bioresource Dihydroartemisinin Sales and Revenue in China Market (2016-2021)
6.7.4 Novanat Bioresource Dihydroartemisinin Product Description
6.7.5 Novanat Bioresource Recent Developments
6.8 Botanical Extracts EPZ Ltd
6.8.1 Botanical Extracts EPZ Ltd Corporation Information
6.8.2 Botanical Extracts EPZ Ltd Overview
6.8.3 Botanical Extracts EPZ Ltd Dihydroartemisinin Sales and Revenue in China Market (2016-2021)
6.8.4 Botanical Extracts EPZ Ltd Dihydroartemisinin Product Description
6.8.5 Botanical Extracts EPZ Ltd Recent Developments
7 China Dihydroartemisinin Production Capacity, Analysis
7.1 China Dihydroartemisinin Production Capacity, 2016-2027
7.2 Dihydroartemisinin Production Capacity of Key Manufacturers in China Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Dihydroartemisinin Supply Chain Analysis
9.1 Dihydroartemisinin Industry Value Chain
9.2 Dihydroartemisinin Upstream Market
9.3 Dihydroartemisinin Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Dihydroartemisinin Distributors and Sales Agents in China Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of TablesTable 1. Key Players of Dihydroartemisinin in China Market
Table 2. Top Dihydroartemisinin Players in China Market, Ranking by Revenue (2019)
Table 3. China Dihydroartemisinin Revenue by Companies, (US$, Mn), 2016-2021
Table 4. China Dihydroartemisinin Revenue Share by Companies, 2016-2021
Table 5. China Dihydroartemisinin Sales by Companies, (K MT), 2016-2021
Table 6. China Dihydroartemisinin Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Dihydroartemisinin Price (2016-2021) & (USD/MT)
Table 8. Manufacturers Dihydroartemisinin Product Type
Table 9. List of Tier 1 Dihydroartemisinin Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Dihydroartemisinin Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Pharmaceutical Grade
Table 12. Major Manufacturers of Industrial Grade
Table 13. By Type - China Dihydroartemisinin Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - China Dihydroartemisinin Revenue (US$, Mn), 2016-2021
Table 15. By Type - China Dihydroartemisinin Revenue (US$, Mn), 2022-2027
Table 16. By Type - China Dihydroartemisinin Sales (K MT), 2016-2021
Table 17. By Type - China Dihydroartemisinin Sales (K MT), 2022-2027
Table 18. By Application - China Dihydroartemisinin Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - China Dihydroartemisinin Revenue (US$, Mn), 2016-2021
Table 20. By Application - China Dihydroartemisinin Revenue (US$, Mn), 2022-2027
Table 21. By Application - China Dihydroartemisinin Sales (K MT), 2016-2021
Table 22. By Application - China Dihydroartemisinin Sales (K MT), 2022-2027
Table 23. Sanofi Corporation Information
Table 24. Sanofi Description and Major Businesses
Table 25. Sanofi Dihydroartemisinin Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 26. Sanofi Dihydroartemisinin Product
Table 27. Sanofi Recent Developments
Table 28. KPC Pharmaceuticals Corporation Information
Table 29. KPC Pharmaceuticals Description and Major Businesses
Table 30. KPC Pharmaceuticals Dihydroartemisinin Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 31. KPC Pharmaceuticals Dihydroartemisinin Product
Table 32. KPC Pharmaceuticals Recent Developments
Table 33. Guangxi Xiancaotang Pharmaceutical Corporation Information
Table 34. Guangxi Xiancaotang Pharmaceutical Description and Major Businesses
Table 35. Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 36. Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Product
Table 37. Guangxi Xiancaotang Pharmaceutical Recent Developments
Table 38. Guilin Pharmaceutical Corporation Information
Table 39. Guilin Pharmaceutical Description and Major Businesses
Table 40. Guilin Pharmaceutical Dihydroartemisinin Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 41. Guilin Pharmaceutical Dihydroartemisinin Product
Table 42. Guilin Pharmaceutical Recent Developments
Table 43. Kerui Nanhai Pharmaceutical Corporation Information
Table 44. Kerui Nanhai Pharmaceutical Description and Major Businesses
Table 45. Kerui Nanhai Pharmaceutical Dihydroartemisinin Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 46. Kerui Nanhai Pharmaceutical Dihydroartemisinin Product
Table 47. Kerui Nanhai Pharmaceutical Recent Developments
Table 48. Shanghai Natural Bio-engineering Co Corporation Information
Table 49. Shanghai Natural Bio-engineering Co Description and Major Businesses
Table 50. Shanghai Natural Bio-engineering Co Dihydroartemisinin Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 51. Shanghai Natural Bio-engineering Co Dihydroartemisinin Product
Table 52. Shanghai Natural Bio-engineering Co Recent Developments
Table 53. Novanat Bioresource Corporation Information
Table 54. Novanat Bioresource Description and Major Businesses
Table 55. Novanat Bioresource Dihydroartemisinin Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 56. Novanat Bioresource Dihydroartemisinin Product
Table 57. Novanat Bioresource Recent Developments
Table 58. Botanical Extracts EPZ Ltd Corporation Information
Table 59. Botanical Extracts EPZ Ltd Description and Major Businesses
Table 60. Botanical Extracts EPZ Ltd Dihydroartemisinin Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 61. Botanical Extracts EPZ Ltd Dihydroartemisinin Product
Table 62. Botanical Extracts EPZ Ltd Recent Developments
Table 63. Dihydroartemisinin Production Capacity (K MT) of Key Manufacturers in China Market, 2019-2021 (K MT)
Table 64. China Dihydroartemisinin Capacity Market Share of Key Manufacturers, 2019-2021
Table 65. Dihydroartemisinin Market Opportunities & Trends in China Market
Table 66. Dihydroartemisinin Market Drivers in China Market
Table 67. Dihydroartemisinin Market Restraints in China Market
Table 68. Dihydroartemisinin Raw Materials
Table 69. Dihydroartemisinin Raw Materials Suppliers in China Market
Table 70. Typical Dihydroartemisinin Downstream
Table 71. Dihydroartemisinin Downstream Clients in China Market
Table 72. Dihydroartemisinin Distributors and Sales Agents in China Market
List of FiguresFigure 1. Dihydroartemisinin Product Picture
Figure 2. Dihydroartemisinin Segment by Type
Figure 3. Dihydroartemisinin Segment by Application
Figure 4. China Dihydroartemisinin Market Overview: 2020
Figure 5. China Dihydroartemisinin Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. China Dihydroartemisinin Revenue, 2016-2027 (US$, Mn)
Figure 7. Dihydroartemisinin Sales in China Market: 2016-2027 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Dihydroartemisinin Revenue in 2020
Figure 9. Pharmaceutical Grade Product Picture
Figure 10. Industrial Grade Product Picture
Figure 11. By Type - China Dihydroartemisinin Sales Market Share, 2016-2027
Figure 12. By Type - China Dihydroartemisinin Revenue Market Share, 2016-2027
Figure 13. By Type - China Dihydroartemisinin Price (USD/MT), 2016-2027
Figure 14. Malaria Treatment
Figure 15. Scientific Research
Figure 16. Others
Figure 17. By Application - China Dihydroartemisinin Sales Market Share, 2016-2027
Figure 18. By Application - China Dihydroartemisinin Revenue Market Share, 2016-2027
Figure 19. By Application - China Dihydroartemisinin Price (USD/MT), 2016-2027
Figure 20. Sanofi Dihydroartemisinin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. KPC Pharmaceuticals Dihydroartemisinin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Guilin Pharmaceutical Dihydroartemisinin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Kerui Nanhai Pharmaceutical Dihydroartemisinin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Shanghai Natural Bio-engineering Co Dihydroartemisinin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Novanat Bioresource Dihydroartemisinin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Botanical Extracts EPZ Ltd Dihydroartemisinin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. China Dihydroartemisinin Production Capacity (K MT), 2016-2027
Figure 29. Dihydroartemisinin Industry Value Chain
Figure 30. Marketing Channels